James Raftery

Summary

Affiliation: University of Southampton
Country: UK

Publications

  1. doi request reprint Health Technology Assessment in the UK
    James Raftery
    University of Southampton, Wessex Institute, Southampton, UK
    Lancet 382:1278-85. 2013
  2. pmc Review of NICE's recommendations, 1999-2005
    James Raftery
    Wessex Institute of Health Research and Development, University of Southampton, Southampton SO16 7PX
    BMJ 332:1266-8. 2006
  3. pmc Possible net harms of breast cancer screening: updated modelling of Forrest report
    James Raftery
    Faculty of Medicine, Wessex Institute, University of Southampton, Southampton SO16 7PX, UK
    BMJ 343:d7627. 2011
  4. doi request reprint Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach
    James Raftery
    School of Medicine, University of Southampton, Southhampton, UK
    Int J Technol Assess Health Care 25:1-5. 2009
  5. pmc "Flogging dead horses": evaluating when have clinical trials achieved sufficiency and stability? A case study in cardiac rehabilitation
    Louise Dent
    University of Southampton Clinical Trials Unit MP131, University of Southampton, SO16 6YD, UK
    Trials 12:83. 2011
  6. ncbi request reprint A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers
    Ruth Davies
    School of Management, University of Southampton, UK
    Health Care Manag Sci 5:249-58. 2002
  7. pmc Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials
    James Raftery
    University of Southampton, Southampton, UK
    Trials 13:140. 2012
  8. pmc Paying clinicians to join clinical trials: a review of guidelines and interview study of trialists
    James Raftery
    Wessex Institute for Health R and D, School of Medicine, University of Southampton, Southampton, UK
    Trials 10:15. 2009
  9. pmc An evaluation of the cost-effectiveness of booklet-based self-management of dizziness in primary care, with and without expert telephone support
    Lucy Yardley
    School of Psychology, University of Southampton, Highfield, Southampton, UK
    BMC Ear Nose Throat Disord 9:13. 2009
  10. doi request reprint The CHD challenge: comparing four cost-effectiveness models
    David Turner
    Wessex Institute University of Southampton, Southampton, UK
    Value Health 14:53-60. 2011

Detail Information

Publications24

  1. doi request reprint Health Technology Assessment in the UK
    James Raftery
    University of Southampton, Wessex Institute, Southampton, UK
    Lancet 382:1278-85. 2013
    ..We identify features that might be of value to other health systems as they confront the challenges of rapid innovation and rising costs. We use examples of recent studies to show the strengths and weaknesses of the programme. ..
  2. pmc Review of NICE's recommendations, 1999-2005
    James Raftery
    Wessex Institute of Health Research and Development, University of Southampton, Southampton SO16 7PX
    BMJ 332:1266-8. 2006
  3. pmc Possible net harms of breast cancer screening: updated modelling of Forrest report
    James Raftery
    Faculty of Medicine, Wessex Institute, University of Southampton, Southampton SO16 7PX, UK
    BMJ 343:d7627. 2011
    ..To assess the claim in a Cochrane review that mammographic breast cancer screening could be doing more harm than good by updating the analysis in the Forrest report, which led to screening in the United Kingdom...
  4. doi request reprint Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach
    James Raftery
    School of Medicine, University of Southampton, Southhampton, UK
    Int J Technol Assess Health Care 25:1-5. 2009
    ..This study assesses the impact of the English National Health Service (NHS) Health Technology Assessment (HTA) program using the "payback" framework...
  5. pmc "Flogging dead horses": evaluating when have clinical trials achieved sufficiency and stability? A case study in cardiac rehabilitation
    Louise Dent
    University of Southampton Clinical Trials Unit MP131, University of Southampton, SO16 6YD, UK
    Trials 12:83. 2011
    ..Measures of sufficiency and stability may indicate whether this is true.Objectives: To show how evidence accumulated on centre-based versus home-based cardiac rehabilitation, including estimates of sufficiency and stability..
  6. ncbi request reprint A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers
    Ruth Davies
    School of Management, University of Southampton, UK
    Health Care Manag Sci 5:249-58. 2002
    ..A factorial design analysis showed the sensitivity of key variables. An increase in the opportunistic testing was found significantly to reduce the impact of screening...
  7. pmc Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials
    James Raftery
    University of Southampton, Southampton, UK
    Trials 13:140. 2012
    ..Formation of the NIHR in 2006 and increased research spending by the Department of Health may have increased the number of noncommercial trials but no data are available...
  8. pmc Paying clinicians to join clinical trials: a review of guidelines and interview study of trialists
    James Raftery
    Wessex Institute for Health R and D, School of Medicine, University of Southampton, Southampton, UK
    Trials 10:15. 2009
    ..The aims were to review relevant guidelines and to collate and analyse views of clinical trialists on the role of payments and other factors that motivated clinicians to join clinical trials...
  9. pmc An evaluation of the cost-effectiveness of booklet-based self-management of dizziness in primary care, with and without expert telephone support
    Lucy Yardley
    School of Psychology, University of Southampton, Highfield, Southampton, UK
    BMC Ear Nose Throat Disord 9:13. 2009
    ..The aim of this trial is to evaluate two new alternative models of delivery that may be more feasible and cost-effective...
  10. doi request reprint The CHD challenge: comparing four cost-effectiveness models
    David Turner
    Wessex Institute University of Southampton, Southampton, UK
    Value Health 14:53-60. 2011
    ....
  11. pmc Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial
    David Turner
    Wessex Institute, University of Southampton, Alpha House, Southampton Science Park, Chilworth, Southampton SO16 7NS
    BMJ 340:c346. 2010
    ..To assess the cost effectiveness of different management strategies for urinary tract infections...
  12. pmc Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
    James Raftery
    Wessex Institute for Health R and D, Medical School, University of Southampton, Southampton, UK
    Br J Ophthalmol 91:1244-6. 2007
    ..Continued unlicensed use of bevacizumab raises ethical, legal and policy questions. Public pressure may be the most potent weapon in persuading Genentech to license bevacizumab for AMD...
  13. ncbi request reprint Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis
    Fujian Song
    Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
    Med Decis Making 22:S26-37. 2002
    ..The cost-effectiveness of adding NRT and bupropion SR to advice or counseling for smoking cessation is better than many other accepted health care interventions...
  14. ncbi request reprint Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis
    Sue Jowett
    Health Economics Facility, Health Services Management Centre, University of Birmingham, Birmingham, UK
    Br J Haematol 134:632-9. 2006
    ..However, PSM may have other benefits in relieving pressure on traditional clinic-based care, and the cost-effectiveness of this model of care for some subgroups of anticoagulation patients needs to be explored further...
  15. pmc Ethnic and sex bias in discretionary awards
    James Raftery
    BMJ 326:671-2. 2003
  16. ncbi request reprint Counting in-hospital deaths in England: a comparison of hospital computer systems and mortuary registers
    Mohammed Mohammed
    Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK
    J Health Serv Res Policy 9:100-3. 2004
    ....
  17. pmc A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]
    Dawn Swancutt
    Department of Primary Care and General Practice, The University of Birmingham, UK
    BMC Cardiovasc Disord 4:12. 2004
    ..The value of clinical assessment and echocardiography as additional methods of risk stratification for thromboembolic disease in patients with AF were also evaluated...
  18. ncbi request reprint Diffusion of thrombolysis for acute myocardial infarction from 1981 to 2000 in England: trend analysis and comparison with need
    Claire Packer
    Department of Public Health and Epidemiology, The University of Birmingham, Edgbaston, UK
    Int J Technol Assess Health Care 20:531-6. 2004
    ..To describe the adoption and take up of thrombolytic agents for acute myocardial infarction since 1980 in England and compare use with the estimated ceiling of need...
  19. ncbi request reprint Comparing processes of stroke care in high- and low-mortality hospitals in the West Midlands, UK
    Mohammed A Mohammed
    Public Health and Epidemiology, Birmingham University, Birmingham, UK
    Int J Qual Health Care 17:31-6. 2005
    ....
  20. ncbi request reprint Can health technologies be assessed using routine data?
    Andrew J Stevens
    Department of Public Health and Epidemiology, University of Birmingham, UK
    Int J Technol Assess Health Care 21:96-103. 2005
    ..The potential of routine data for health technology assessment (HTA) in the United Kingdom was assessed...
  21. ncbi request reprint Predicting the impact of new health technologies on average length of stay: development of a prediction framework
    Sue Simpson
    Dept of Public Health and Epidemiology, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Int J Technol Assess Health Care 21:487-91. 2005
    ..The aim of this study was to develop a framework to predict the impact of new health technologies on average length of hospital stay...
  22. ncbi request reprint 'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation
    Miren Jones
    Department of Primary Care and General Practice, University of Birmingham, Birmingham, UK
    Fam Pract 24:343-57. 2007
    ..Cardiac rehabilitation (CR) has been shown to improve prognosis and function following an acute myocardial infarction or revascularization. However, participation in CR programmes is low and adherence is poor...
  23. ncbi request reprint Assessing the economic challenges posed by orphan drugs: a comment on Drummond et al
    Christopher McCabe
    Int J Technol Assess Health Care 23:397-401; author reply 401-4. 2007
  24. ncbi request reprint NHS activity. Running out of juice
    James Raftery
    Health Services Management Centre, Birmingham University
    Health Serv J 112:22-3. 2002
    ..Current measurement indicators do not take account of quality, so improvement to services may show up as decreases in efficiency. Quality improvements should be included in productivity measurement...